Why is Mankind Pharma falling/rising?

As of 30-Jul, Mankind Pharma Ltd's stock price is currently at Rs 2,562.50, reflecting an increase of Rs 9.65 or 0.38%. The stock has shown a positive trend recently, gaining 1.04% over the last two days and reaching an intraday high of Rs 2,610, which is a 2.24% increase. Despite a 2.54% decline over the past week, the stock has performed well over the past month with a 10.32% increase. The company exhibits strong fundamentals, including a high return on equity (ROE) of 17.22% and a low debt-to-EBITDA ratio of 0.69, indicating efficient management and a solid ability to service its debt. Additionally, the stock has outperformed the broader market, generating a 24.64% return over the past year while the market has seen a slight decline.
In the broader market context, Mankind Pharma's recent performance contrasts with the benchmark index, the Sensex, which has declined by 1.50% over the past week. While the stock has faced challenges year-to-date with a 10.93% drop, its strong institutional holdings at 24.58% suggest confidence from knowledgeable investors, which may contribute to its recent upward movement. The stock's liquidity is also favorable, with a delivery volume increase of 29.19% compared to the five-day average, indicating rising investor participation. Overall, the combination of solid financial metrics, recent positive performance, and strong institutional support contributes to the stock's current upward trajectory.